asaren 70 Dasatinib Ketoconazole
MajorStrong CYP3A4 inhibition greatly raises dasatinib exposure, increasing myelosuppression, fluid retention and QT risk.
These medicines can affect each other in a serious way. Do not start taking them together unless your doctor has said it is OK. If you already take both, do not stop either one on your own: speak to your doctor or pharmacist soon.
Clinical management: Avoid; if unavoidable, reduce dasatinib dose and monitor closely.